NEW YORK, Nov. 22, 2017 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced results for the quarter ended September 30, 2017, and provided an overview of recent operational highlights. Read More
The post Axim Biotechnologies Reports Third Quarter 2017 Results appeared first on Dagga Magazine.